Where is Structure Therapeutics headquartered?

Structure Therapeutics is located in San Francisco, CA.

Who invested in Structure Therapeutics?

Structure Therapeutics has 13 investors including Geekdom Fund And Geekdom Fund.

How much funding has Structure Therapeutics raised to date?

Structure Therapeutics has raised ____.

When was the last funding round for Structure Therapeutics?

Structure Therapeutics closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

structuretx.com

Structure Therapeutics

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

Business Model:

Revenue: $5M

Employees: 2-10

Geographic Data

Address: 701 Gateway Blvd

City: San Francisco

State: CA

Zip: 94080

Country: US

Financial Info

Stage:

series b

Raised Last:

$33M

Raised Total:

$207M

Social

Twitter

Crunchbase

Metrics

2,263,445Website Global Rank

9,983Website Monthly Traffic

Twitter Followers

Description

Structure Therapeutics creates life-changing medicines for patients using advanced computational and structure-based technology. Our platform combines the latest advancements in computational chemistry, visualization of molecular interactions, and data integration to design orally available, superior medicines that overcome current limitations in biologic and peptide drugs. We are advancing our clinical-stage pipeline of differentiated, efficacious and safe treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic and pulmonary conditions. At Structure, our team’s deep experience with complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development enables our bold vision: to design and develop world-class medicines with tremendous patient impact and broad commercial opportunity.

Contact Phone:

Contact Email:

IPO Details

Structure Therapeutics went public on the NASDAQ

Listed Exchange:
NASDAQ

Ticker Symbol:
GPCR

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
10/2021	Venture Round		$32M
2/2023	IPO		$185.3M
7/2022	Series B		$33M	Deep Track Capital Piper Heartland Healthcare Capital
3/2020	Series A	1	$26M	Qiming Venture Partners Qiming Venture Partners
8/2022	Series B	2	$33M	Deep Track Capital Piper Heartland Healthcare Capital Deep Track Capital Piper Heartland Healthcare Capital
4/2019	Series A	2	$16M	Qiming Venture Partners F-Prime Capital
10/2021	Series B		$0	BVF Partners Casdin Capital Cormorant Asset Management Eight Roads Ventures F-Prime Capital Janus Henderson Investors Lilly Asia Ventures Monashee Capital Corp. Qiming Venture Partners Schrödinger Sequoia Capital China Stork Capital Surveyor Capital TCG Crossover Terra Magnum Capital Partners (""""TMCP"""")"" TF Capital Woodline Partners WuXi AppTec BVF Partners Casdin Capital Cormorant Asset Management Eight Roads Ventures F-Prime Capital Janus Henderson Investors Lilly Asia Ventures Monashee Capital Corp. Qiming Venture Partners Schrödinger Sequoia Capital China Stork Capital Surveyor Capital TCG Crossover Terra Magnum Capital Partners (""""TMCP"""")"" TF Capital Woodline Partners WuXi AppTec
10/2021	Series B	18	$100M	BVF Partners Casdin Capital Cormorant Asset Management Eight Roads Ventures F-Prime Capital Janus Henderson Investors Lilly Asia Ventures Monashee Capital Corp. Qiming Venture Partners Schrödinger Sequoia Capital China Stork Capital Surveyor Capital TCG Crossover Terra Magnum Capital Partners (""""TMCP"""")"" TF Capital Woodline Partners WuXi AppTec BVF Partners Casdin Capital Cormorant Asset Management Eight Roads Ventures F-Prime Capital Janus Henderson Investors Lilly Asia Ventures Monashee Capital Corp. Qiming Venture Partners Schrödinger Sequoia Capital China Stork Capital Surveyor Capital TCG Crossover Terra Magnum Capital Partners (""""TMCP"""")"" TF Capital Woodline Partners WuXi AppTec

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details